| Drug Name |
Testosterone undecanoate |
| Drug ID |
BADD_D02174 |
| Description |
Testosterone undecanoate is the ester prodrug of testosterone and has a midchain fatty acid at the 17Beta position. [A176753] It is available as an intramuscular injection and as an oral capsule, and is indicated for treatment of testosterone deficiency. [F4247][FDA Label] It should be noted that testosterone undecanoate is only indicated for treatment of hypogonadal conditions with structural or genetic etiologies and should not be used to manage "age-related hypogonadism". [FDA Label] |
| Indications and Usage |
Testosterone undecanoate is indicated for replacement therapy in adult males with conditions that are linked with an absence or deficiency in endogenous testosterone production. [F4247][FDA Label] |
| Marketing Status |
approved; investigational |
| ATC Code |
Not Available |
| DrugBank ID |
DB13946
|
| KEGG ID |
D06087
|
| MeSH ID |
C010792
|
| PubChem ID |
65157
|
| TTD Drug ID |
D02AXG
|
| NDC Product Code |
80603-103; 10745-1444; 49803-003; 69087-158; 69087-237; 0009-5036; 11014-0386; 60722-3007; 67979-511; 69087-198; 80603-105; 60722-0009; 22552-0013; 60870-0465; 73774-008; 54436-112; 11014-0385; 48087-0135; 51552-1598; 80603-101; 11014-0387 |
| UNII |
H16A5VCT9C
|
| Synonyms |
testosterone undecanoate | testosterone undecylate | Andriol | Restandol | Pantestone | Nebido | Undestor |
